Direct Oral Anticoagulants versus Vitamin K Antagonists for the treatment of Left Ventricular Thrombosis: a systematic review of the literature and meta-analysis.

[1]  S. Antoniou,et al.  The Use of Novel Oral Anti-Coagulant's (NOAC) compared to Vitamin K Antagonists (Warfarin) in patients with Left Ventricular thrombus after Acute Myocardial Infarction (AMI). , 2020, European heart journal. Cardiovascular pharmacotherapy.

[2]  K. Witte,et al.  Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus , 2020, ESC heart failure.

[3]  G. Lip,et al.  Left Ventricular Thrombosis: New Perspectives on an Old Problem. , 2020, European heart journal. Cardiovascular pharmacotherapy.

[4]  E. Stecker,et al.  Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges , 2020, Journal of the American Heart Association.

[5]  C. Kramer,et al.  Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi. , 2020, JAMA cardiology.

[6]  E. Vicaut,et al.  Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus. , 2020, Journal of the American College of Cardiology.

[7]  K. Isaaz,et al.  Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists , 2020, Clinical Drug Investigation.

[8]  J. Loh,et al.  A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus , 2018, Journal of Thrombosis and Thrombolysis.

[9]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[10]  Michele Tarsilla Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.